INTRODUCTION In acne vulgaris, the cornerstone of topical treatment is retinoid therapy, including tretinoin (the first topical retinoid used in acne and the gold standard for several years).1 Retinoids, and…

INTRODUCTION Hippocrates said, "Let foods be thy medicine." Nutrition plays a key role in health and wellness. Poor nutrition contributes to aging and significantly increases the risk of developing systemic…

INTRODUCTION Over the last few decades, multiple advancements in skin rejuvenation techniques have provided dermatologists with a myriad of options for enhancing the cosmetic appearance of skin. Most important, many…

OVERVIEW AND TECHNIQUE Initially introduced in Italy in 1985, microdermabrasion (MDA) remains a popular cosmetic procedure today. The process involves rapid propulsion of abrasive microcrystals, usually aluminum oxide, at the…

INTRODUCTION White coat hypertension (WCHTN) refers to a clinical phenomenon characterized by elevated blood pressure (BP) when patients are in the doctor's office, where systolic BP ≥140 mm Hg, diastolic…

INTRODUCTION Acne vulgaris is one of the most common dermatologic diseases that affect more than 90% of individuals during their lifetimes.1 Caused by inflammation of the pilosebaceous glands, acne vulgaris…

INTRODUCTION Long-term ultraviolet (UV) radiation facilitates the development of skin tumors. Lerche et al have reported that TCIs, including topical pimecrolimus and tacrolimus, did not accelerate photocarcinogenesis in hairless mice…

INTRODUCTION Flap viability depends on adequate blood flow in relation to the tissue-specific metabolic demands. Severed nutrient blood vessels and surgical denervation result in immediate reduction in perfusion pressure and…

INTRODUCTION Discoid lupus erythematosus (DLE) is a subtype of lupus erythematosus which presents mainly in areas above the neck include the nose, malar region, and ears.1 It is characterized clinically…

Duke Dermatology is a leader in advanced treatment of skin disease. The first Chief of Duke Dermatology was Dr. J. Lamar Callaway, a founding member of the Society of Investigative…

INTRODUCTION Antiphospholipid antibody syndrome (APS) can cause catastrophic thrombotic events, with cutaneous manifestations as the first sign of APS in up to 41% of patients.1 It is important to promptly…

INTRODUCTION Chemotherapy agents contribute to a number of side effects in the skin. This table highlights the major cutaneous adverse reactions in commonly used chemotherapy agents.DISCLOSURES The authors have disclosed…